Entera Bio Ltd. (NASDAQ:ENTX) Q3 2019 Earnings Conference Call November 21, 2019 8:30 AM ET Company Participants Adam Gridley - Chief Executive Officer Phillip Schwartz - President of R&D Arth Santora - Chief Medical Officer Dana Yaacov-Garbeli - Interim Chief Financial Officer Conference Call Participants Joanne Lee - Maxim Group Operator Good morning. My name is Sonia, and I'll be your conference operator today. At this time, I would like to welcome everyone to the Entera Bio Third Quarter 2019 Conference ...

Entera Bio Ltd. (NASDAQ:ENTX) Q2 2019 Earnings Conference Call August 20, 2019 8:30 AM ET Company Participants Bob Yedid - LifeSci Advisors Adam Gridley - CEO Phillip Schwartz - President of Research and Development Dana Yaacov-Garbeli - Interim CFO Conference Call Participants Naureen Quibria - Maxim Group Operator Good morning. My name is Rob, and I will be your conference operator today. At this time, I would like to welcome everyone to the Entera Bio Second Quarter 2019 Conference Call. All lines have b ...

Entera Bio Ltd. (NASDAQ:ENTX) Q4 2018 Results Earnings Conference Call March 28, 2019 10:00 AM ET Company Participants Michael Wood - LifeSci Advisors Phillip Schwartz - CEO Mira Rosenzweig - CFO Conference Call Participants Naureen Quibria - Maxim Group Operator Greetings. Welcome to Entera Bio Fourth Quarter and Fiscal Year 2018 Earnings Conference Call. At this time, all participants are in listen-only mode. [Operator Instructions] As a reminder, this conference is being recorded. I'd now turn the confer ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 (Mark One) FORM 20-F ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2018 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ___ to ___ . OR ☐ SHELL COMPANY REPORT PURSUANT TO SECTION 13 O ...